Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLV vs GSK✓SelectedUSD · GSKXLV vs GSK performance historyLatest closeAs of-0.12%11/20
Stock and ETF performance explorer

XLV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+964.3%
GSK return
+145.7%
Excess return
+818.7%
Maximum drawdown
-39.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D-6.1%-5.3%-0.8%-4.1%
30D-1.0%-3.7%+2.7%+0.4%
3M+3.2%-7.3%+10.5%+6.1%
6M+21.5%-4.2%+25.7%+23.2%
YTD+15.9%+0.9%+15.0%+14.8%
1Y+19.0%+7.3%+11.7%+15.1%
3Y+44.4%+52.7%-8.3%+19.3%
5Y+44.6%+40.1%+4.5%+21.7%
10Y+200.6%+98.7%+101.9%+118.8%
All+964.3%+145.7%+818.7%+539.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling